Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3213 INDIA– AdvaMed worked with the health ministry to develop globally harmonized rules for medical devices, an interim step to a comprehensive framework for regulation of devices as distinct from drugs. In coordination with industry stakeholders, the Association intensified its advocacy and PR efforts in opposition to mounting political pressures for coronary stent price controls, delaying their implementation and helping to protect patient access to innovation. The Association will continue to work with India’s government and other stakeholders to increase awareness of the value of medtech and improve patient access to needed care. JAPAN– Successful AdvaMed advocacy helped ensure that Japan did not change its reimbursement rules in 2016 to move from biennial to annual rate adjustments, saving the industry hundreds of millions of dollars. Japan also continued to make progress under an AdvaMed-supported regulatory performance plan aimed at improving patient access to innovation. LATIN AMERICA– In Brazil, AdvaMed partnered with medtech associations in the country to stave off price controls, promote the value of medtech, and evaluate regulatory and health technology assessment gaps to help improve access to innovation. AdvaMed also worked with industry across Latin America to strengthen codes of ethics and compliance throughout the hemisphere. EUROPEAN UNION– As the EU moved toward completion of revisions to its regulatory system for devices and diagnostics, AdvaMed worked in close collaboration with MedTech Europe (an alliance of European medtech industry associations) to address key issues and press for maintaining the safety and efficiency of the EU’s current, decentralized regulatory approach. These efforts, which included organizing meetings between AdvaMed members and officials in EU member states, appeared to be successful in the final text. Robert Gates, former U.S. secretary of defense and CIA director (at left), discusses the strategic and geopolitical landscape impacting global trade with AdvaMed Chairman Vincent Forlenza of BD (center) and AdvaMed’s Ralph Ives, at the March CEO Summit in Newport Coast, Calif. AdvaMed International Board Committee Chairman Kevin Lobo of Stryker (lower right) speaks at a CEO Mentoring Moments session at AdvaMed 2016. Lord David Prior, UK parliamentary under-secretary of state for health, participates in a discussion on the impact of Brexit on medtech at AdvaMed 2016 in October, adjacent Star Tribune reporter Joe Carlson.